Abeer Fatima3 months ago
Therapeutic Agents and Osteonecrosis of the Jaw
The osteonecrosis of the jaw can occur as a result of disrupted blood supply. Processes like radiotherapy, medications with tendency to disrupt blood flow, high-dose steroid therapy, and disruption in bone turnover can implicate in osteonecrosis of the jaw. Medication associated with risk of osteonecrosis of the jaw are listed as under: - Pamidronate - Alendronate - Risedronate - Ibandronate - Zoledronic acid - Clodronate - Denosumab - Tiludronate - Imatinib - Bevacizumab - Sorafenib - Etidronate - Sunitinib Reference: https://www.nature.com/articles/s41413-020-0088-1 Image via: https://www.rdhmag.com/pathology/article/14197577/risks-of-medicationrelated-osteonecrosis-of-the-jaw-in-cancer-patients
Other commentsSign in to post comments. You don't have an account? Sign up now!
Related posts
Breastfeeding and Medications IVBreastfeeding and Medications VPregnancy and Contraindicated Medications IIIPregnancy and Contraindicated Medications IVMedicines for Weightless IIIMedicines for Weightless IVMedicines for Weightless VEmergency MedicationsHypertension MedicationsBisphosphonate-induced osteonecrosis.
